The global blood group typing market revenue was around US$ 2.23 billion in 2022 and is estimated to reach US$ 4.23 billion by 2031, growing at a compound annual growth rate (CAGR) of 7.4% during the forecast period from 2023 to 2031.
Blood group typing is a testing procedure under which an individual blood group is identified and classified into AB, A, B, and O using laboratory tests. Blood group typing is necessary to determine the existence of the Rhesus (Rh) factor, test donor blood, and transfuse blood compatibility with the recipient patient.
Market Driving Factors
Growing road traffic accidents such as speeding, drunk driving, and distracted driving boost the market growth. This is because the demand for blood transfusions rising due to significant blood loss in traffic accidents. For instance, in June 2022, according to the World Health Organisation estimates around 1.3 million persons die each year in road traffic accidents worldwide.
Increasing the prevalence of thalassemia globally with surging migrations boosts the market growth. A person with thalassemia has lower hemoglobin than the average person owing to an inherited blood illness. Therefore, blood group typing technologies would increase significantly for timely diagnosis of treatment and thalassemia.
The scarcity of infrastructure and trained personnel for these procedures in emerging countries limits market growth.
Regional Analysis
North America dominated the market in terms of the largest share and is estimated to maintain its dominance. Blood group typing in the region is a critical element of transfusion medicine. The region boasts cutting-edge healthcare infrastructure, allowing widespread access to proper typing services. Furthermore, strict legal requirements guarantee accurate blood type, which is essential for organ transplants and safe transfusions. The prevalence of chronic illnesses and the elderly population further emphasizes the importance of precise blood typing in the region.
Asia-Pacific is expected to dominate the market in terms of the highest growth. Blood group typing in the region is essential to transfusion medicine. Precise typing is required for safe transfusions and organ transplants due to the diverse population's many ethnicities and blood types. Furthermore, cutting-edge techniques, such as Polymerase chain reaction (PCR) and next-generation sequencing (NGS) are increasingly adopted to improve accuracy. The high prevalence of operations and chronic illnesses in the region emphasizes the significance of accurate blood type.
Segmentation Insights
Product Type Insight
The consumables segment dominated the market in terms of revenue. This can be mainly driven by the surge in surgical procedures such as organ transplantation, which requires the usage of serological fluids and reagents in laboratories. The escalating rate of blood donations, leading to a higher volume of blood sample analyses, is also a substantial contributing element. Furthermore, the development of diagnostic test reagents and kits aimed at expediting definitive results is anticipated to support this growth.
Test Type Insight
The ABO blood tests segment dominates the market. This is due to their vital role in healthcare. These tests assist in determining an individual's A, AB, B, or O blood type which is critical for organ transplants and safe blood transfusions. The rising demand for blood transfusions, an increase in trauma cases, and a growth in surgical procedures have all contributed to the requirement for accurate ABO testing. In addition, ABO blood tests also play an important role in forensics, prenatal care, and personalized medicine. Furthermore, advancements in testing techniques, offer precise and rapid outcomes, ensuring effective medical interventions and patient safety. Therefore, this factor drives the market in the region.
Technique Insight
The assay-based techniques segment dominates the market in terms of the share. These techniques are precise in determining blood group antigens, which makes them crucial in ensuring safe blood transfusions and booming organ transplants. The continued development of these methods, incorporating cutting-edge technologies such as solid-phase assays and gel card assays, improves their accuracy and sensitivity.
Prominent Companies
Segmentation Outline
The global blood group typing market segmentation focuses on Product Type, Test Type, Technique, and Region.
By Product Type
By Test Type
By Technique
By Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL BLOOD GROUP TYPING MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY: BLOOD GROUP TYPING MARKET
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS
4 GLOBAL BLOOD GROUP TYPING MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE
5 GLOBAL BLOOD GROUP TYPING MARKET, BY PRODUCT TYPE
5.1 OVERVIEW
5.2 INSTRUMENTS
5.3 CONSUMABLES
5.4 SERVICES
6 GLOBAL BLOOD GROUP TYPING MARKET, BY TEST TYPE
6.1 OVERVIEW
6.2 HLA TYPING
6.3 ABO BLOOD TEST
6.4 ANTIBODY SCREENING
6.5 CROSS-MATCHING TESTS
6.6 ANTIGEN TYPING
7 GLOBAL BLOOD GROUP TYPING MARKET, BY TECHNIQUE
7.1 OVERVIEW
7.2 ASSAY-BASED TECHNIQUES
7.3 PCR-BASED AND MICROARRAY TECHNIQUES
7.4 MASSIVELY PARALLEL SEQUENCING TECHNIQUES
7.5 OTHERS
8 GLOBAL BLOOD GROUP TYPING MARKET, BY GEOGRAPHY
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO
8.3 EUROPE
8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1 THE UK
8.3.2.2 GERMANY
8.3.2.3 FRANCE
8.3.2.4 ITALY
8.3.2.5 SPAIN
8.3.2.6 REST OF WESTERN EUROPE
8.3.3 EASTERN EUROPE
8.3.3.1 POLAND
8.3.3.2 RUSSIA
8.3.3.3 REST OF EASTERN EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA
8.6 SOUTH AMERICA
8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA
9 GLOBAL BLOOD GROUP TYPING MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES
9.4 COMPETITIVE DASHBOARD
9.5 PRODUCT MAPPING
9.6 TOP PLAYER POSITIONING, 2022
9.7 COMPETITIVE HEATMAP
9.8 TOP WINNING STRATEGIES
10 COMPANY PROFILES
10.1 BIO-RAD LABORATORIES INC
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS
10.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.2 BIO ARRAY SOLUTIONS LTD
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS
10.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.3 BIOMÉRIEUX
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS
10.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.4 DANAHER CORPORATION
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS
10.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.5 GRIFOLS INTERNATIONAL S.A.
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS
10.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.6 IMMUCOR INC
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS
10.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.7 MERCK KGAA
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS
10.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.8 ORTHO CLINICAL DIAGNOSTICS INC
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS
10.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.9 QUOTIENT LIMITED
10.9.1 OVERVIEW
10.9.2 FINANCIAL PERFORMANCE
10.9.3 PRODUCT OUTLOOK
10.9.4 KEY DEVELOPMENTS
10.9.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.10 REAGEN LLC
10.10.1 OVERVIEW
10.10.2 FINANCIAL PERFORMANCE
10.10.3 PRODUCT OUTLOOK
10.10.4 KEY DEVELOPMENTS
10.10.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.11 SEKISUI MEDICAL CO. LTD
10.11.1 OVERVIEW
10.11.2 FINANCIAL PERFORMANCE
10.11.3 PRODUCT OUTLOOK
10.11.4 KEY DEVELOPMENTS
10.11.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.12 THERMO FISHER SCIENTIFIC INC
10.12.1 OVERVIEW
10.12.2 FINANCIAL PERFORMANCE
10.12.3 PRODUCT OUTLOOK
10.12.4 KEY DEVELOPMENTS
10.12.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.13 TULIP DIAGNOSTICS (P) LIMITED
10.13.1 OVERVIEW
10.13.2 FINANCIAL PERFORMANCE
10.13.3 PRODUCT OUTLOOK
10.13.4 KEY DEVELOPMENTS
10.13.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.14 WIESLAB AB
10.14.1 OVERVIEW
10.14.2 FINANCIAL PERFORMANCE
10.14.3 PRODUCT OUTLOOK
10.14.4 KEY DEVELOPMENTS
10.14.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved